Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case

被引:19
|
作者
Connor, Bradley A. [1 ,2 ,3 ]
Couto-Rodriguez, Mara [4 ]
Barrows, Joseph E. [4 ]
Gardner, Morgan [2 ,3 ]
Rogova, Marina [2 ,3 ]
O'Hara, Niamh B. [4 ,5 ]
Nagy-Szakal, Dorottya [4 ,5 ]
机构
[1] Weill Cornell Med, New York, NY 10021 USA
[2] New York Ctr Travel & Trop Med, New York, NY 10022 USA
[3] GeoSentinel, New York, NY 12201 USA
[4] Biotia Inc, New York, NY USA
[5] SUNY Downstate Hlth Sci Univ, Dept Cell Biol, Coll Med, New York, NY USA
关键词
B; 1; 617; 2; Delta variant; SARS-CoV-2; COVID-19; variant of concern; breakthrough; monoclonal antibody therapy; bamlanivimab; etesevimab;
D O I
10.1016/j.ijid.2021.07.029
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We present two Delta (B.1.617.2) vaccine breakthrough individuals, a father and son living in separate households. The older, 63-year-old patient's symptoms were severe enough to require hospitalization. De-spite having a high titer of anti-spike IgG in his serum, his symptoms resolved within 24 hours following monoclonal antibody (bamlanivimab/etesevimab) therapy. (c) 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页码:232 / 234
页数:3
相关论文
共 50 条
  • [31] Insights on the interaction of SARS-CoV-2 variant B.1.617.2 with antibody CR3022 and analysis of antibody resistance
    Sandhya KS
    Achuthsankar S. Nair
    Journal of Genetic Engineering and Biotechnology, 21
  • [32] Infection and Transmission of SARS-CoV-2 B.1.617.2 Lineage (Delta Variant) among Fully Vaccinated Individuals
    Caserta, Leonardo C.
    Martins, Mathias
    Cronk, Brittany
    Anderson, Renee
    Eldridge, Harry
    Gallow, Deidre
    Kruppa, Frank
    Plocharczyk, Elizabeth
    Diel, Diego G.
    MICROBIOLOGY SPECTRUM, 2022, 10 (05):
  • [33] Active viral shedding in a vaccinated hospitalized patient infected with the delta variant (B.1.617.2) of SARS-CoV-2 and challenges of de-isolation
    Alshukairi, Abeer N.
    Al-Omari, Awad
    Al-Tawfiq, Jaffar A.
    El-Kafrawy, Sherif A.
    El-Daly, Mai M.
    Hassan, Ahmed M.
    Faizo, Arwa A.
    Alandijany, Thamir A.
    Dada, Ashraf
    Saeedi, Mohammed F.
    Alhamlan, Fatma S.
    Hroub, Mohammad K. Al
    Qushmaq, Ismael
    Azhar, Esam I.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2022, 15 (06) : 628 - 630
  • [34] Inequalities associated with emergence of Delta SARS-CoV-2 variant of concern (B.1.617.2) in England: awareness for future variants
    Leeman, D.
    Campos-Matos, I.
    Dabrera, G.
    PUBLIC HEALTH, 2022, 205 : E14 - E15
  • [35] The latent period of coronavirus disease 2019 with SARS-CoV-2 B.1.617.2 Delta variant of concern in the postvaccination era
    Ma, Tao
    Ding, Songning
    Huang, Rui
    Wang, Hengxue
    Wang, Junjun
    Liu, Jiacheng
    Wang, Jian
    Li, Jie
    Wu, Chao
    Fan, Huafeng
    Zhou, Nan
    IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (07)
  • [36] SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant
    Taytard, Jessica
    Prevost, Blandine
    Schnuriger, Aurelie
    Aubertin, Guillaume
    Berdah, Laura
    Bitton, Lauren
    Dupond-Athenor, Audrey
    Thouvenin, Guillaume
    Nathan, Nadia
    Corvol, Harriet
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [37] Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscape
    Manojit Bhattacharya
    Srijan Chatterjee
    Ashish Ranjan Sharma
    Sang-Soo Lee
    Chiranjib Chakraborty
    Folia Microbiologica, 2023, 68 : 17 - 28
  • [38] Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscape
    Bhattacharya, Manojit
    Chatterjee, Srijan
    Sharma, Ashish Ranjan
    Lee, Sang-Soo
    Chakraborty, Chiranjib
    FOLIA MICROBIOLOGICA, 2023, 68 (01) : 17 - 28
  • [39] An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021
    Hetemaki, Iivo
    Kaariainen, Sohvi
    Alho, Pirjo
    Mikkola, Janne
    Savolainen-Kopra, Carita
    Ikonen, Niina
    Nohynek, Hanna
    Lyytikainen, Outi
    EUROSURVEILLANCE, 2021, 26 (30)
  • [40] Association of the Delta (B.1.617.2) Variant of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) With Pregnancy Outcomes
    Wang, Amanda M.
    Berry, Marissa
    Moutos, Christopher P.
    Omere, Chasey
    Clark, Shannon M.
    Harirah, Hassan M.
    Jain, Sangeeta
    Olson, Gayle L.
    Pacheco, Luis D.
    Saade, George R.
    Saad, Antonio F.
    OBSTETRICS AND GYNECOLOGY, 2021, 138 (06): : 838 - 841